Gender differences in ghrelin association with cardiometabolic risk factors in arab population

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Abu Farha, Mohamed ^a   Dehbi, Mohammed ^b   Noronha, Fiona ^a   Tiss, Ali ^a   Alarouj, Monira ^a   Behbehani, Kazem ^a   Bennakhi, Abdullah ^a   Elkum, Naser ^a,c  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

^b HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

^c SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; ARAB; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KUWAIT; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84935002319     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/730472     Document Type: Article

References (37)

1. D. I. Koleva, M. M. Orbetzova, and P. K. Atanassova, "Adipose tissue hormones and appetite and body weight regulators in insulin resistance," Folia Medica, vol. 55, no. 1, pp. 25-32, 2013.
2. A. Laviano, A. Molfino, S. Rianda, and F. Rossi Fanelli, "The growth hormone secretagogue receptor (GHs-R)," Current Pharmaceutical Design, vol. 18, no. 31, pp. 4749-4754, 2012.
3. O. Ukkola, "Ghrelin in type 2 diabetes mellitus and metabolic syndrome," Molecular and Cellular Endocrinology, vol. 340, no. 1, pp. 26-28, 2011.
4. I. Kishimoto, T. Tokudome, H. Hosoda, M. Miyazato, and K. Kangawa, "Ghrelin and cardiovascular diseases," Journal of Cardiology, vol. 59, no. 1, pp. 8-13, 2012.
5. J. Isgaard and R. Granata, "Ghrelin in cardiovascular disease and atherogenesis," Molecular and Cellular Endocrinology, vol. 340, no. 1, pp. 59-64, 2011.
6. M. Scerif, A. P. Goldstone, and M. Korbonits, "Ghrelin in obesity and endocrine diseases,"Molecular and Cellular Endocrinology, vol. 340, no. 1, pp. 15-25, 2011.
7. M. Tesauro, F. Schinzari, M. Caramanti, R. Lauro, and C. Cardillo, "Metabolic and cardiovascular effects of ghrelin," International Journal of Peptides, vol. 2010, Article ID 864342, 7 pages, 2010.
8. A. S. Go, D. Mozaffarian, V. L. Roger, E. J. Benjamin, and J. D. Berry, "Heart disease and stroke statistics-2013 update: A report from the American Heart Association," Circulation, vol. 127, pp. e6-e245, 2013.
9. H. S. Mattu and H. S. Randeva, "Role of adipokines in cardiovascular disease," Journal of Endocrinology, vol. 216, no. 1, pp. T17-T36, 2013.
10. V. Regitz-Zagrosek, E. Lehmkuhl, and M. O.Weickert, "Gender differences in the metabolic syndrome and their role for cardiovascular disease," Clinical Research in Cardiology, vol. 95, pp. 136-147, 2006.
11. J. Makovey, V. Naganathan, M. Seibel, and P. Sambrook, "Gender differences in plasma ghrelin and its relations to body composition and bone-an opposite-sex twin study," Clinical Endocrinology, vol. 66, no. 4, pp. 530-537, 2007.
12. C. Hajat,O. Harrison, and Z. Al Siksek, "Weqaya: A populationwide cardiovascular screening program in Abu Dhabi, United Arab Emirates,"The American Journal of Public Health, vol. 102, no. 5, pp. 909-914, 2012.
13. N. Elkum, M. Al-Arouj, M. Sharifi, K. Behbehani, and A. Bennakhi, "Cardiovascular disease risk factors in the South Asian population living in Kuwait: A cross-sectional study," Diabetic Medicine, vol. 31, no. 5, pp. 531-539, 2014.
14. M. Abu-Farha, K. Behbehani, and N. Elkum, "Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs," Cardiovascular Diabetology, vol. 13, article 76, 2014.
15. M. Stepién, K. Rosniak-Bak, M. Paradowski et al., "Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: Preliminary results," Medical Science Monitor, vol. 17, no. 11, pp. PR13-PR18, 2011.
16. P. J. D. Delhanty and A. J. Van Der Lely, "Ghrelin and glucose homeostasis," Peptides, vol. 32, no. 11, pp. 2309-2318, 2011.
17. L. P. Shearman, S.-P.Wang, S. Helmling et al., "Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in dietinduced obese mice," Endocrinology, vol. 147, no. 3, pp. 1517-1526, 2006.
18. D. E. Cummings, D. S. Weigle, R. Scott Frayo et al., "Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery,"The New England Journal of Medicine, vol. 346, no. 21, pp. 1623-1630, 2002.
19. M. M. Scott, M. Perello, J.-C. Chuang et al., "Hindbrain ghrelin receptor signaling is sufficient tomaintain fasting glucose," PLoS ONE, vol. 7, no. 8,Article ID e44089, 2012.
20. G. Pradhan, S. L. Samson, andY. Sun, "Ghrelin:muchmore than a hunger hormone," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 6, pp. 619-624, 2013.
21. X. Yin, Y. Li, G. Xu,W. An, andW. Zhang, "Ghrelin fluctuation, what determines its production?" Acta Biochimica et Biophysica Sinica, vol. 41, no. 3, pp. 188-197, 2009.
22. M. Kojima and K. Kangawa, "Ghrelin: Structure and function," Physiological Reviews, vol. 85, no. 2, pp. 495-522, 2005.
23. L. Pacifico, E. Poggiogalle, F. Costantino et al., "Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome," European Journal of Endocrinology, vol. 161, no. 6, pp. 861-870, 2009.
24. T. McLaughlin, F. Abbasi, C. Lamendola, R. S. Frayo, and D. E. Cummings, "Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive contrls," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 4, pp. 1630-1635, 2004.
25. Y. Zhao, L. Shao, L. Teng, D. Zhang, and H. Zhang, "Relationship between plasma ghrelin levels and insulin resistance and blood pressure in octogenarians," Journal of Huazhong University of Science and Technology-Medical Science, vol. 30, no. 3, pp. 307-311, 2010.
26. P. Amini, D.Wadden, F. Cahill et al., "Serum acylated ghrelin is negatively correlated with the insulin resistance in theCODING study," PLoS ONE, vol. 7, no. 9,Article ID e45657, 2012.
27. K. M. Heppner, C. L. Piechowski, A. Müller et al., "Both acyl and des-acyl ghrelin regulate adiposity and glucosemetabolism via central nervous system ghrelin receptors," Diabetes, vol. 63, no. 1, pp. 122-131, 2014.
28. S. Pöykkö, O. Ukkola, H. Kauma, M. J. Savolainen, and Y. A. Kesäniemi, "Ghrelin Arg51Glnmutation is a risk factor for Type 2 diabetes and hypertension in a randomsample of middle-aged subjects," Diabetologia, vol. 46, no. 4, pp. 455-458, 2003.
29. C. Schöfl, R. Horn, T. Schill, H. W. Schlösser, M. J. Müller, and G. Brabant, "Circulating ghrelin levels in patients with polycystic ovary syndrome," Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 10, pp. 4607-4610, 2002.
30. P. J.Delhanty, S. J. Neggers, andA. J. Van Der Lely, "Mechanisms in endocrinology: Ghrelin: The differences between acyl-and des-acyl ghrelin," European Journal of Endocrinology, vol. 167, no. 5, pp. 601-608, 2012.
31. J. N. Freeman, J. M. D. Carmo, A. H. Adi, and A. A. da Silva, "Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats," Peptides, vol. 42, pp. 35-42, 2013.
32. J. Hlebowicz, S. Lindstedt, O. Björgell, and M. Dencker, "The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure," Cardiovascular Ultrasound, vol. 9, no. 1, article 43, 2011.
33. K. Mizia-Stec, B. Zahorska-Markiewicz, M. Olszanecka-Glinianowicz et al., "Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment," Endokrynologia Polska, vol. 59, no. 3, pp. 207-211, 2008.
34. A. Rodríguez, J. Gómez-Ambrosi, V. Catalán et al., "Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome," Journal of Hypertension, vol. 28, no. 3, pp. 560-567, 2010.
35. N. Nagaya, M. Kojima, M. Uematsu et al., "Hemodynamic and hormonal effects of human ghrelin in healthy volunteers," American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 280, no. 5, pp. R1483-R1487, 2001.
36. Y.Makino, H. Hosoda, K. Shibata et al., "Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy," Hypertension, vol. 39, no. 3, pp. 781-784, 2002.
37. Z.-F. Li, D.-X. Zhou, W.-Z. Pan, L. Zhang, and J.-B. Ge, "Circulating ghrelin was negatively correlated with pulmonary arterial pressure in atrial septal defect patients," ChineseMedical Journal, vol. 126, no. 20, pp. 3936-3939, 2013.